Early Blood Pressure Variables Associated With Improved Outcomes in VA-ECLS: The ELSO Registry Analysis.

ELSO blood pressure hemodynamics outcomes veno-arterial extracorporeal life support (VA-ECLS)

Journal

JACC. Heart failure
ISSN: 2213-1787
Titre abrégé: JACC Heart Fail
Pays: United States
ID NLM: 101598241

Informations de publication

Date de publication:
06 2022
Historique:
received: 03 01 2022
revised: 14 03 2022
accepted: 01 04 2022
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

As utilization of veno-arterial extracorporeal life support (VA-ECLS) in treatment of cardiogenic shock (CS) continues to expand, clinical variables that guide clinicians in early recognition of myocardial recovery and therefore, improved survival, after VA-ECLS are critical. There remains a paucity of literature on early postinitiation blood pressure measurements that predict improved outcomes. The objective of this study is to help identify early blood pressure variables associated with improved outcomes in VA-ECLS. The authors queried the ELSO (Extracorporeal Life Support Organization) registry for cardiogenic shock patients treated with VA-ECLS or venovenous arterial ECLS between 2009 and 2020. Their inclusion criteria included treatment with VA-ECLS or venovenous arterial ECLS; absence of pre-existing durable right, left, or biventricular assist devices; no pre-ECLS cardiac arrest; and no surgical or percutaneously placed left ventricular venting devices during their ECLS runs. Their primary outcome of interest was the survival to discharge during index hospitalization. A total of 2,400 CS patients met the authors' inclusion criteria and had complete documentation of blood pressures. Actual mortality during index hospitalization in their cohort was 49.5% and survivors were younger and more likely to be Caucasian, intubated for >30 hours pre-ECLS initiation, and had a favorable baseline SAVE (Survival After Veno-arterial ECMO) score (P < 0.05 for all). Multivariable regression analyses adjusting for SAVE score, age, ECLS flow at 4 hours, and race showed that every 10-mm Hg increase in baseline systolic blood pressure (HR: 0.92 [95% CI: 0.89-0.95]; P < 0.001), and baseline pulse pressure (HR: 0.88 [95% CI: 0.84-0.91]; P < 0.001) at 24 hours was associated with a statistically significant reduction in mortality. Early (within 24 hours) improvements in pulse pressure and systolic blood pressure from baseline are associated with improved survival to discharge among CS patients treated with VA-ECLS.

Sections du résumé

BACKGROUND
As utilization of veno-arterial extracorporeal life support (VA-ECLS) in treatment of cardiogenic shock (CS) continues to expand, clinical variables that guide clinicians in early recognition of myocardial recovery and therefore, improved survival, after VA-ECLS are critical. There remains a paucity of literature on early postinitiation blood pressure measurements that predict improved outcomes.
OBJECTIVES
The objective of this study is to help identify early blood pressure variables associated with improved outcomes in VA-ECLS.
METHODS
The authors queried the ELSO (Extracorporeal Life Support Organization) registry for cardiogenic shock patients treated with VA-ECLS or venovenous arterial ECLS between 2009 and 2020. Their inclusion criteria included treatment with VA-ECLS or venovenous arterial ECLS; absence of pre-existing durable right, left, or biventricular assist devices; no pre-ECLS cardiac arrest; and no surgical or percutaneously placed left ventricular venting devices during their ECLS runs. Their primary outcome of interest was the survival to discharge during index hospitalization.
RESULTS
A total of 2,400 CS patients met the authors' inclusion criteria and had complete documentation of blood pressures. Actual mortality during index hospitalization in their cohort was 49.5% and survivors were younger and more likely to be Caucasian, intubated for >30 hours pre-ECLS initiation, and had a favorable baseline SAVE (Survival After Veno-arterial ECMO) score (P < 0.05 for all). Multivariable regression analyses adjusting for SAVE score, age, ECLS flow at 4 hours, and race showed that every 10-mm Hg increase in baseline systolic blood pressure (HR: 0.92 [95% CI: 0.89-0.95]; P < 0.001), and baseline pulse pressure (HR: 0.88 [95% CI: 0.84-0.91]; P < 0.001) at 24 hours was associated with a statistically significant reduction in mortality.
CONCLUSIONS
Early (within 24 hours) improvements in pulse pressure and systolic blood pressure from baseline are associated with improved survival to discharge among CS patients treated with VA-ECLS.

Identifiants

pubmed: 35654524
pii: S2213-1779(22)00241-4
doi: 10.1016/j.jchf.2022.04.003
pmc: PMC9214574
mid: NIHMS1817222
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-403

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL141596
Pays : United States

Informations de copyright

Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

JAMA. 1989 Feb 10;261(6):884-8
pubmed: 2913385
Eur Heart J. 2015 Sep 1;36(33):2246-56
pubmed: 26033984
Circulation. 2019 Dec 10;140(24):2019-2037
pubmed: 31815538
J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50
pubmed: 25534305
Crit Care Med. 2008 May;36(5):1404-11
pubmed: 18434909
ASAIO J. 2020 Feb;66(2):141-145
pubmed: 30864968
Crit Care. 2019 Jan 11;23(1):11
pubmed: 30635022
J Crit Care. 2012 Oct;27(5):524.e7-14
pubmed: 22386227
Intensive Care Med. 2011 Nov;37(11):1738-45
pubmed: 21965097
Eur J Cardiothorac Surg. 2014 Jan;45(1):47-54
pubmed: 23616484
Artif Organs. 2010 Feb;34(2):E59-64
pubmed: 20420591
Am J Cardiol. 2004 Mar 15;93(6):785-8
pubmed: 15019896
Resuscitation. 2013 Oct;84(10):1404-8
pubmed: 23603288
Artif Organs. 2019 Feb;43(2):132-141
pubmed: 30402887
Semin Thorac Cardiovasc Surg. 2015 Summer;27(2):81-8
pubmed: 26686427
Ann Cardiothorac Surg. 2019 Jan;8(1):E1-E8
pubmed: 30854330
Int J Cardiol. 2009 Jan 24;131(3):336-44
pubmed: 18192039
J Cardiothorac Vasc Anesth. 2015 Aug;29(4):906-11
pubmed: 25836952

Auteurs

Aniket S Rali (AS)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: Aniket.rali@vumc.org.

Sagar Ranka (S)

Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Amy Butcher (A)

Department of Cardiovascular Anesthesia and Critical Care, Baylor College of Medicine, Houston, Texas, USA.

Zubair Shah (Z)

Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Joseph E Tonna (JE)

Division of Cardiothoracic Surgery, Department of Surgery, University of Utah Health, Salt Lake City, Utah, USA.

Marc M Anders (MM)

Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Marshal D Brinkley (MD)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Hasan Siddiqi (H)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Lynn Punnoose (L)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Mark Wigger (M)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Suzanne B Sacks (SB)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Dawn Pedrotty (D)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Henry Ooi (H)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Matthew D Bacchetta (MD)

Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Jordan Hoffman (J)

Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

William McMaster (W)

Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Keki Balsara (K)

Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Ashish S Shah (AS)

Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Jonathan N Menachem (JN)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Kelly H Schlendorf (KH)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

JoAnn Lindenfeld (J)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Sandip K Zalawadiya (SK)

Division of Cardiovascular Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH